|
|
||||||||
Animal: DNA Viruses |
Department of Clinical Virology, Göteborg University, Guldhedsgatan 10B, S-413 46 Göteborg, Sweden1
Department of Microbiology and Immunology, University of British Columbia, 300-6174 University Boulevard, Vancouver, BC, CanadaV6T 1Z32
Author for correspondence: Kristina Mårdberg. Fax +46 31 82 70 32. e-mail Kristina.Mardberg{at}microbio.gu.se
The role of glycoprotein C (gC) for binding of herpes simplex virus type 1 (HSV-1) to cell surface chondroitin sulfate (CS) and the consequences of this interaction for virus attachment and infectivity were studied. To this end, a panel of HSV-1 gC mutants, including a gC-negative (gC-) variant, and mouse fibroblasts expressing either cell surface CS or heparan sulfate (HS) were used. Comparing gC-positive (gC+) and gC- viruses in terms of their attachment to and infection of CS-expressing cells indicated that gC was essential for both functions. Furthermore, purified gC bound efficiently to isolated CS chains. However, hypertonic NaCl disrupted this interaction more easily as compared to the binding of gC to HS. Also, native and selectively desulfated heparins were approximately 10 times more efficient at inhibiting gC binding to CS-expressing cells than binding to HS-expressing cells. Experiments with the HSV-1 gC mutants revealed that specific, positively charged and hydrophobic amino acids within the N-terminal part of the protein were responsible for efficient binding as well as infectivity in both CS- and HS-expressing cells. When the infectivity of the gC mutants in the two cell types was compared, it appeared that more residues contributed to the infection of CS-expressing cells than to infection of HS-expressing cells. Taken together, analysis of gC function in cell systems with limited expression of glycosaminoglycans revealed that gC could interact with either CS or HS and that these interactions exhibited subtle but definite differences as regards to the involved structural features of gC, ionic strength dependency as well as sensitivity to specifically desulfated heparin compounds.
This article has been cited by other articles:
![]() |
T. Ghosh, K. Chattopadhyay, M. Marschall, P. Karmakar, P. Mandal, and B. Ray Focus on antivirally active sulfated polysaccharides: From structure-activity analysis to clinical evaluation Glycobiology, January 1, 2009; 19(1): 2 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Knappe, S. Bodevin, H.-C. Selinka, D. Spillmann, R. E. Streeck, X. S. Chen, U. Lindahl, and M. Sapp Surface-exposed Amino Acid Residues of HPV16 L1 Protein Mediating Interaction with Cell Surface Heparan Sulfate J. Biol. Chem., September 21, 2007; 282(38): 27913 - 27922. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uyama, M. Ishida, T. Izumikawa, E. Trybala, F. Tufaro, T. Bergstrom, K. Sugahara, and H. Kitagawa Chondroitin 4-O-Sulfotransferase-1 Regulates E Disaccharide Expression of Chondroitin Sulfate Required for Herpes Simplex Virus Infectivity J. Biol. Chem., December 15, 2006; 281(50): 38668 - 38674. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jenssen, P. Hamill, and R. E. W. Hancock Peptide Antimicrobial Agents Clin. Microbiol. Rev., July 1, 2006; 19(3): 491 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bergefall, E. Trybala, M. Johansson, T. Uyama, S. Naito, S. Yamada, H. Kitagawa, K. Sugahara, and T. Bergstrom Chondroitin Sulfate Characterized by the E-disaccharide Unit Is a Potent Inhibitor of Herpes Simplex Virus Infectivity and Provides the Virus Binding Sites on gro2C Cells J. Biol. Chem., September 16, 2005; 280(37): 32193 - 32199. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mardberg, K. Nystrom, M. A. Tarp, E. Trybala, H. Clausen, T. Bergstrom, and S. Olofsson Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity Glycobiology, July 1, 2004; 14(7): 571 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marozin, U. Prank, and B. Sodeik Herpes simplex virus type 1 infection of polarized epithelial cells requires microtubules and access to receptors present at cell-cell contact sites J. Gen. Virol., April 1, 2004; 85(4): 775 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okuma, K. P. Dalton, L. Buonocore, E. Ramsburg, and J. K. Rose Development of a Novel Surrogate Virus for Human T-Cell Leukemia Virus Type 1: Inhibition of Infection by Osteoprotegerin J. Virol., August 1, 2003; 77(15): 8562 - 8569. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |